1. Cost of antiretroviral treatment for HIV patients in two centres of North India.
- Author
-
Sharma, Atul, Prinja, Shankar, Sharma, Aman, Gupta, Aditi, and Arora, Sunil K
- Subjects
HIV-positive persons ,THERAPEUTICS ,ANTIRETROVIRAL agents ,DRUG prices ,MEDICAL care costs ,HIV infection epidemiology ,MEDICAL care cost statistics ,HIV infections ,COST analysis ,HIGHLY active antiretroviral therapy ,ANTI-HIV agents ,AIDS serodiagnosis - Abstract
There is paucity of evidence on cost of antiretroviral therapy (ART) delivered through the public sector in India. Moreover, the Government of India is considering changing the criteria for introduction of ART to HIV patients, which is likely to have significant economic implications. In this paper, we assess the health system cost of ART services at two levels of health care delivery. Bottom-up costing was used to collect data on capital and recurrent resources consumed over a period of one year (April 2014–March 2015). Capital costs were annualized and shared costs apportioned to calculate annual and unit costs of providing ART care. Sensitivity analysis was undertaken to measure the extent of uncertainty in input prices. The annual per capita cost of ART therapy was INR 48,975 (USD738) in the Centre of Excellence (COE) and INR 24,954 (USD376) in the ART centre. Drugs contributed around 70% and 65% of total annual cost, followed by human resource (19% each) and capital cost (7%; 12%) in COE and ART centres, respectively. These provide a comprehensive assessment of the cost of ART care in India. The study estimates could be used for planning of services, as well as undertaking further cost-effectiveness studies. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF